Silent Information Regulator 1 (SIRT1) has also been identified as a master regulator in endocrine and metabolic diseases, such as hyperuricemia, diabetes, hypertension, hyperlipidemia, osteoporosis, and polycystic ovary syndrome [98]. Here, SIRT1 is linked to hyperlipidemia.